EWSR1 anticorps (N-Term)
Aperçu rapide pour EWSR1 anticorps (N-Term) (ABIN633586)
Antigène
Voir toutes EWSR1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- EWSR1 antibody was raised against the N terminal of EWSR1
-
Purification
- Affinity purified
-
Immunogène
- EWSR1 antibody was raised using the N terminal of EWSR1 corresponding to a region with amino acids PQVPGSYPMQPVTAPPSYPPTSYSSTQPTSYDQSSYSQQNTYGQPSSYGQ
-
-
-
-
Indications d'application
-
WB: 0.5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
EWSR1 Blocking Peptide, (ABIN5613422), is also available for use as a blocking control in assays to test for specificity of this EWSR1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EWSR1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- EWSR1 (Ewing Sarcoma Breakpoint Region 1 (EWSR1))
-
Autre désignation
- EWSR1
-
Sujet
- EWSR1 is a putative RNA binding protein. Mutations in this gene, specifically a t(11,22)(q24,q12) translocation, are known to cause Ewing sarcoma as well as neuroectodermal and various other tumors.
-
Poids moléculaire
- 52 kDa (MW of target protein)
Antigène
-